Fabrinet, Adecoagro And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Group 1 - U.S. stock futures showed mixed results, with S&P 500 futures declining approximately 0.1% [1] - Fabrinet reported better-than-expected fourth-quarter financial results for fiscal 2025, with expected first-quarter revenue between $910 million and $950 million, slightly below estimates of $916.72 million [2] - Fabrinet's expected first-quarter adjusted earnings are projected to be between $2.75 and $2.90 per share, slightly above the estimate of $2.74 per share [2] Group 2 - Fabrinet shares fell 9.7% to $295.54 in pre-market trading following the earnings report [2] - Xunlei Limited experienced a decline of 8.4% to $8.05 in pre-market trading after a significant increase of around 38% on the previous day [4] - Precigen, Inc. shares dipped 5.8% to $2.78 in pre-market trading after the FDA approved PAPZIMEOS [4] - Adecoagro S.A. shares fell 4.5% to $8.79 in pre-market trading after reporting disappointing quarterly results [4] - Immatics NV shares decreased by 3.9% to $5.97 in pre-market trading [4] - Tonix Pharmaceuticals Holding Corp shares fell 3.9% to $38.51 in pre-market trading following FDA approval of Tonmya for fibromyalgia in adults [4]